Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: A meta-analysis and systematic review

Although numerous studies have reported the prognostic value of the lung immune prognostic index (LIPI) in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs), the prognostic value of the LIPI in a pancancer setting remains unclear.